962 related articles for article (PubMed ID: 17306374)
21. Pharmacological characterization and antidiabetic activity of a long-acting glucagon-like peptide-1 analogue conjugated to an antithrombin III-binding pentasaccharide.
Patterson S; de Kort M; Irwin N; Moffett RC; Dokter WH; Bos ES; Miltenburg AM; Flatt PR
Diabetes Obes Metab; 2015 Aug; 17(8):760-70. PubMed ID: 25929155
[TBL] [Abstract][Full Text] [Related]
22. The structure and function of the glucagon-like peptide-1 receptor and its ligands.
Donnelly D
Br J Pharmacol; 2012 May; 166(1):27-41. PubMed ID: 21950636
[TBL] [Abstract][Full Text] [Related]
23. Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes.
Luque MA; González N; Márquez L; Acitores A; Redondo A; Morales M; Valverde I; Villanueva-Peñacarrillo ML
J Endocrinol; 2002 Jun; 173(3):465-73. PubMed ID: 12065236
[TBL] [Abstract][Full Text] [Related]
24. Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans.
Koska J; Sands M; Burciu C; D'Souza KM; Raravikar K; Liu J; Truran S; Franco DA; Schwartz EA; Schwenke DC; D'Alessio D; Migrino RQ; Reaven PD
Diabetes; 2015 Jul; 64(7):2624-35. PubMed ID: 25720388
[TBL] [Abstract][Full Text] [Related]
25. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
[TBL] [Abstract][Full Text] [Related]
26. Glucagon-Like Peptide-1 Receptor Agonist and Glucagon Increase Glucose-Stimulated Insulin Secretion in Beta Cells via Distinct Adenylyl Cyclases.
Lee YS; Jun HS
Int J Med Sci; 2018; 15(6):603-609. PubMed ID: 29725251
[TBL] [Abstract][Full Text] [Related]
27. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ
Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840
[TBL] [Abstract][Full Text] [Related]
28. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
[TBL] [Abstract][Full Text] [Related]
29. Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats.
Valverde I; Wang GS; Burghardt K; Kauri LM; Redondo A; Acitores A; Villanueva-Peñacarrillo ML; Courtois P; Sener A; Cancelas J; Malaisse WJ; Scott FW
Endocrine; 2004 Feb; 23(1):77-84. PubMed ID: 15034199
[TBL] [Abstract][Full Text] [Related]
30. [The physiology of glucagon-like peptide-1 and its role in the pathophysiology of type 2 diabetes mellitus].
Escalada FJ
Med Clin (Barc); 2014 Sep; 143 Suppl 2():2-7. PubMed ID: 25437458
[TBL] [Abstract][Full Text] [Related]
31. Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cells.
Koehler JA; Kain T; Drucker DJ
Endocrinology; 2011 Sep; 152(9):3362-72. PubMed ID: 21771884
[TBL] [Abstract][Full Text] [Related]
32. Calcium/calmodulin-dependent serine protein kinase is involved in exendin-4-induced insulin secretion in INS-1 cells.
Zhu ZQ; Wang D; Xiang D; Yuan YX; Wang Y
Metabolism; 2014 Jan; 63(1):120-6. PubMed ID: 24140090
[TBL] [Abstract][Full Text] [Related]
33. Brain GLP-1 signaling regulates femoral artery blood flow and insulin sensitivity through hypothalamic PKC-δ.
Cabou C; Vachoux C; Campistron G; Drucker DJ; Burcelin R
Diabetes; 2011 Sep; 60(9):2245-56. PubMed ID: 21810595
[TBL] [Abstract][Full Text] [Related]
34. The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice.
Maida A; Lovshin JA; Baggio LL; Drucker DJ
Endocrinology; 2008 Nov; 149(11):5670-8. PubMed ID: 18669601
[TBL] [Abstract][Full Text] [Related]
35. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
[TBL] [Abstract][Full Text] [Related]
36. GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody.
Pyke C; Heller RS; Kirk RK; Ørskov C; Reedtz-Runge S; Kaastrup P; Hvelplund A; Bardram L; Calatayud D; Knudsen LB
Endocrinology; 2014 Apr; 155(4):1280-90. PubMed ID: 24467746
[TBL] [Abstract][Full Text] [Related]
37. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.
Li Y; Hansotia T; Yusta B; Ris F; Halban PA; Drucker DJ
J Biol Chem; 2003 Jan; 278(1):471-8. PubMed ID: 12409292
[TBL] [Abstract][Full Text] [Related]
38. Roux-en-Y gastric bypass-induced improvement of glucose tolerance and insulin resistance in type 2 diabetic rats are mediated by glucagon-like peptide-1.
Liu Y; Zhou Y; Wang Y; Geng D; Liu J
Obes Surg; 2011 Sep; 21(9):1424-31. PubMed ID: 21479766
[TBL] [Abstract][Full Text] [Related]
39. An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis.
Baggio LL; Huang Q; Cao X; Drucker DJ
Gastroenterology; 2008 Apr; 134(4):1137-47. PubMed ID: 18313669
[TBL] [Abstract][Full Text] [Related]
40. Intra-islet glucagon confers β-cell glucose competence for first-phase insulin secretion and favors GLP-1R stimulation by exogenous glucagon.
Cabrera O; Ficorilli J; Shaw J; Echeverri F; Schwede F; Chepurny OG; Leech CA; Holz GG
J Biol Chem; 2022 Feb; 298(2):101484. PubMed ID: 34896391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
